Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Steve Riley | Researchclopedia

Back to researchers

Steve Riley

Pfizer (United States)ORCID

87

Works

4,311

Citations

18

h-index

24

i10-index

Research Topics

Cardiac electrophysiology and arrhythmias Amyloidosis: Diagnosis, Treatment, Outcomes Pharmacogenetics and Drug Metabolism

Affiliations

Northwestern University2017–2017

University of Padua2014–2014

Innsbruck Medical University2014–2014

Pfizer (United States)2006–2025

University of Pavia2017–2017

Top Works

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Matthew J. Maurer,Jeffrey H. Schwartz,et al.

20182,608 citations

Pharmaceutical studies and practices

Pharmacology and Obesity Treatment

Scientific white paper on concentration-QTc modeling

Christine Garnett,Peter L. Bonate,et al.

2017250 citations

Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension study

Thibaud Damy,Pablo García‐Pavía,et al.

2020204 citations

Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance

Wonkyung Byon,Michael K. Smith,et al.

2013183 citations

Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis

Teresa Coelho,Giampaolo Merlini,et al.

2016180 citations

Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase

Börje Darpö,Charles Benson,et al.

2015177 citations

The IQ‐CSRC Prospective Clinical Phase 1 Study: “Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study?”

Börje Darpö,Nenad Sarapa,et al.

201399 citations

Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Matthew J. Maurer,Perry Elliott,et al.

201783 citations

Cardiac Safety Research Consortium: Can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward

Börje Darpö,Christine Garnett,et al.

201461 citations